Double vs. triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: does clinical presentation matter? - Sorbonne Université
Journal Articles European Heart Journal - Cardiovascular Pharmacotherapy Year : 2020

Double vs. triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: does clinical presentation matter?

Domains

Cardiology and cardiovascular system

Gestionnaire HAL 5 Sorbonne Université  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03101399

Submitted on : Thursday, January 7, 2021-10:06:03 AM

Last modification on : Thursday, December 14, 2023-1:50:37 PM

No file

Dates and versions

hal-03101399 , version 1 (07-01-2021)

Identifiers

Cite

Andrea Rubboli, Jean-Philippe Collet. Double vs. triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: does clinical presentation matter?. European Heart Journal - Cardiovascular Pharmacotherapy, 2020, ⟨10.1093/ehjcvp/pvaa121⟩. ⟨hal-03101399⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

ICAN SORBONNE-UNIVERSITE SU-MEDECINE IHU_ICAN
12 View
0 Download

Altmetric

Share

More